Justice Department antitrust division looking at health care conglomerates, pharmacy drug middlemen
Newswire
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Pharmacy Benefit Managers Are Killing Indie Pharmacies and Limiting Patient Choice
Rally outside Optum HQ spotlights debate over pharmacy benefits managers
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
TRICARE becomes part of fight over pharmacy benefit managers
A PBM Oligopoly: Three Companies Control 80% Of US Prescriptions – How Can We Fix It?
States Keep Legal Pressure on PBMs Ahead of Potential FTC Suit
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
CVS Caremark agrees to $45M settlement with Illinois: report
Pharmacy middlemen claim to keep prescription prices low. In fact, they’ve cost consumers billions
Insurers, employers see payoffs switching to smaller PBMs
FTC plans to sue top 3 PBMs over insulin prices: WSJ
PBMs pay higher prices to their own pharmacies, FTC says
Health insurers cover fewer drugs and make them harder to get
Spanberger Joins More Than 20 Colleagues in a Bipartisan, Bicameral Effort Urging the Defense Health Agency to Increase Oversight of Its Exclusive Contract with Express Scripts
3Axis Report Scrutinizes PBM Spread Pricing Practice
Independent local pharmacies at risk as reimbursement environment prompting closures
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
We Need Your Support Today!